Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Positron Emission Tomography Computed Tomography | 4 | 2024 | 42 | 2.390 |
Why?
|
| Sarcoidosis | 2 | 2023 | 27 | 1.660 |
Why?
|
| Lymphadenopathy | 2 | 2021 | 23 | 1.470 |
Why?
|
| Cerebral Infarction | 1 | 2024 | 75 | 0.900 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2021 | 80 | 0.900 |
Why?
|
| Radiopharmaceuticals | 2 | 2021 | 172 | 0.870 |
Why?
|
| Pancreas | 3 | 2018 | 146 | 0.710 |
Why?
|
| Melanoma | 2 | 2023 | 334 | 0.710 |
Why?
|
| Vaccination | 1 | 2021 | 337 | 0.630 |
Why?
|
| Biliary Tract | 1 | 2018 | 7 | 0.610 |
Why?
|
| Multimodal Imaging | 1 | 2018 | 67 | 0.580 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2018 | 106 | 0.560 |
Why?
|
| Neoplasms | 1 | 2021 | 1234 | 0.370 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2024 | 1454 | 0.360 |
Why?
|
| Lung Neoplasms | 3 | 2022 | 547 | 0.350 |
Why?
|
| Humans | 21 | 2024 | 59303 | 0.270 |
Why?
|
| Diagnosis, Differential | 5 | 2021 | 895 | 0.270 |
Why?
|
| Immunoconjugates | 2 | 2021 | 84 | 0.250 |
Why?
|
| Ultrasonography | 2 | 2018 | 449 | 0.240 |
Why?
|
| Radioactive Tracers | 1 | 2024 | 2 | 0.240 |
Why?
|
| Biological Transport | 1 | 2024 | 287 | 0.220 |
Why?
|
| Pancreatitis | 2 | 2014 | 101 | 0.220 |
Why?
|
| Dissent and Disputes | 1 | 2022 | 8 | 0.210 |
Why?
|
| Bone Marrow | 1 | 2023 | 174 | 0.200 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2022 | 75 | 0.200 |
Why?
|
| Sarcopenia | 1 | 2022 | 21 | 0.190 |
Why?
|
| Transanal Endoscopic Surgery | 1 | 2022 | 23 | 0.190 |
Why?
|
| Kidney Neoplasms | 1 | 2022 | 114 | 0.190 |
Why?
|
| Prostatic Neoplasms | 1 | 2024 | 326 | 0.190 |
Why?
|
| Catheter Ablation | 1 | 2022 | 137 | 0.180 |
Why?
|
| Rectal Neoplasms | 1 | 2022 | 97 | 0.180 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2021 | 65 | 0.180 |
Why?
|
| Carcinoma, Signet Ring Cell | 1 | 2020 | 6 | 0.170 |
Why?
|
| Neoplasms, Second Primary | 1 | 2020 | 40 | 0.170 |
Why?
|
| Ampulla of Vater | 1 | 2020 | 13 | 0.170 |
Why?
|
| Patient Safety | 1 | 2022 | 243 | 0.170 |
Why?
|
| Simulation Training | 1 | 2019 | 58 | 0.160 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2017 | 2034 | 0.150 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2018 | 50 | 0.150 |
Why?
|
| Laparoscopy | 1 | 2022 | 385 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2021 | 198 | 0.150 |
Why?
|
| Lymphoma, T-Cell | 1 | 2017 | 21 | 0.140 |
Why?
|
| Pelvic Pain | 1 | 2016 | 20 | 0.140 |
Why?
|
| Abdomen, Acute | 1 | 2016 | 24 | 0.140 |
Why?
|
| Disease Progression | 1 | 2021 | 1039 | 0.140 |
Why?
|
| Atrial Flutter | 1 | 2016 | 20 | 0.140 |
Why?
|
| Education, Medical, Graduate | 1 | 2019 | 304 | 0.130 |
Why?
|
| Air Pollutants, Occupational | 1 | 2016 | 76 | 0.130 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2016 | 57 | 0.130 |
Why?
|
| Testicular Neoplasms | 1 | 2016 | 32 | 0.130 |
Why?
|
| Male | 9 | 2024 | 27480 | 0.130 |
Why?
|
| Radiology | 1 | 2019 | 230 | 0.120 |
Why?
|
| Jejunal Diseases | 1 | 2014 | 8 | 0.120 |
Why?
|
| Duodenal Diseases | 1 | 2014 | 17 | 0.120 |
Why?
|
| Communication | 1 | 2019 | 552 | 0.120 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2016 | 233 | 0.120 |
Why?
|
| Choristoma | 1 | 2014 | 24 | 0.120 |
Why?
|
| Colon, Descending | 1 | 2014 | 2 | 0.120 |
Why?
|
| Colonic Diseases | 1 | 2014 | 34 | 0.110 |
Why?
|
| Occupational Exposure | 1 | 2016 | 306 | 0.110 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 391 | 0.100 |
Why?
|
| Aged | 2 | 2024 | 13285 | 0.090 |
Why?
|
| Acute Disease | 3 | 2016 | 658 | 0.080 |
Why?
|
| Treatment Outcome | 4 | 2022 | 5141 | 0.080 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2007 | 20 | 0.070 |
Why?
|
| Aniline Compounds | 1 | 2007 | 28 | 0.070 |
Why?
|
| Stroke | 1 | 2016 | 1135 | 0.070 |
Why?
|
| Positron-Emission Tomography | 1 | 2007 | 170 | 0.070 |
Why?
|
| Neuroblastoma | 1 | 2007 | 85 | 0.070 |
Why?
|
| Female | 6 | 2022 | 30798 | 0.060 |
Why?
|
| Microwaves | 1 | 2022 | 15 | 0.050 |
Why?
|
| Radiologists | 1 | 2022 | 74 | 0.050 |
Why?
|
| Rectum | 1 | 2022 | 82 | 0.050 |
Why?
|
| Salvage Therapy | 1 | 2021 | 73 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 301 | 0.050 |
Why?
|
| SEER Program | 1 | 2020 | 63 | 0.040 |
Why?
|
| Pneumonectomy | 1 | 2020 | 82 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 196 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 450 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 672 | 0.040 |
Why?
|
| Educational Measurement | 1 | 2019 | 207 | 0.040 |
Why?
|
| Survival Rate | 1 | 2020 | 787 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 399 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2020 | 262 | 0.040 |
Why?
|
| Lymphoma, Extranodal NK-T-Cell | 1 | 2017 | 2 | 0.040 |
Why?
|
| Lymphoma, T-Cell, Peripheral | 1 | 2017 | 4 | 0.040 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2017 | 8 | 0.030 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2017 | 7 | 0.030 |
Why?
|
| Enoxaparin | 1 | 2016 | 15 | 0.030 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 48 | 0.030 |
Why?
|
| Facial Paralysis | 1 | 2016 | 12 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2016 | 70 | 0.030 |
Why?
|
| Pelvis | 1 | 2016 | 57 | 0.030 |
Why?
|
| Abdomen | 1 | 2016 | 89 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 869 | 0.030 |
Why?
|
| Aphasia | 1 | 2016 | 42 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 606 | 0.030 |
Why?
|
| Electric Countershock | 1 | 2016 | 98 | 0.030 |
Why?
|
| Middle Aged | 3 | 2020 | 16231 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2022 | 1127 | 0.030 |
Why?
|
| Curriculum | 1 | 2019 | 550 | 0.030 |
Why?
|
| Rupture | 1 | 2014 | 22 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2019 | 677 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 2323 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2014 | 190 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2016 | 485 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2019 | 722 | 0.020 |
Why?
|
| Contrast Media | 1 | 2014 | 408 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2022 | 5967 | 0.020 |
Why?
|
| United States | 1 | 2022 | 7492 | 0.020 |
Why?
|
| Pregnancy | 1 | 2016 | 2352 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 1447 | 0.020 |
Why?
|
| Copper Radioisotopes | 1 | 2007 | 1 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2007 | 158 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2007 | 375 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 1370 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 15729 | 0.010 |
Why?
|
| Mice | 1 | 2007 | 10254 | 0.010 |
Why?
|
| Animals | 1 | 2007 | 19608 | 0.010 |
Why?
|